Nutreco co-led a $49.8m round for the mycoprotein ingredient developer and University of Strathclyde spinout that included Axa.

UK-based mycoprotein producer Enough raised €42m ($49.8m) today in a series B round co-led by animal nutrition specialist Nutreco and Olympic Investments, the private investment arm of the Onassis Foundation. The round also featured Axa IM Alts, which is part of insurance group Axa and which invested through its Axa Impact Fund-Climate & Biodiversity vehicle,…

The rest of this content is only accessible to Corporate Venturing: News, Data, and Events - Global Corporate Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.